<ref>https://en.wikipedia.org/wiki/Ethylenediaminetetraacetic_acid#Alternative_medicine [..] Certains praticiens alternatifs pensent que l'EDTA agit comme un antioxydant, empêchant les radicaux libres d'endommager les parois des vaisseaux sanguins, réduisant ainsi l' athérosclérose.[14] Ces idées ne sont pas étayées par des études scientifiques et semblent contredire certains principes actuellement acceptés.[15] La FDA américaine ne l'a pas approuvé pour le traitement de l'athérosclérose.[16]</ref><ref>https://www.ftc.gov/sites/default/files/documents/cases/1998/12/9623147att.htm ACAM has agreed to settle a civil dispute with the Federal Trade Commission (FTC) involving information we disseminated to the public about chelation therapy. [...]</ref> <ref>https://www.researchgate.net/publication/288643548_Deaths_associated_with_EDTA_chelation_therapy_-_A_systematic_review February 2009. Edzard Ernst.<br>Abstract: <br>Chelation therapy with EDTA is used by alternative practitioners against arteriosclerotic diseases. This systematic review summarizes the deaths that have been associated with it since 1990. Extensive literature searches located 1105 articles of which 6 met the inclusion criteria. They reported 9 fatalities. The quality of these reports was too poor to establish causality beyond doubt. It is concluded that EDTA chelation continues to be associated with fatal outcomes.<br>[Traduction DeepL: ] | <ref>https://en.wikipedia.org/wiki/Ethylenediaminetetraacetic_acid#Alternative_medicine [..] Certains praticiens alternatifs pensent que l'EDTA agit comme un antioxydant, empêchant les radicaux libres d'endommager les parois des vaisseaux sanguins, réduisant ainsi l' athérosclérose.[14] Ces idées ne sont pas étayées par des études scientifiques et semblent contredire certains principes actuellement acceptés.[15] La FDA américaine ne l'a pas approuvé pour le traitement de l'athérosclérose.[16]</ref><ref>https://www.ftc.gov/sites/default/files/documents/cases/1998/12/9623147att.htm ACAM has agreed to settle a civil dispute with the Federal Trade Commission (FTC) involving information we disseminated to the public about chelation therapy. [...]</ref> <ref>https://www.researchgate.net/publication/288643548_Deaths_associated_with_EDTA_chelation_therapy_-_A_systematic_review February 2009. Edzard Ernst.<br>Abstract: <br>Chelation therapy with EDTA is used by alternative practitioners against arteriosclerotic diseases. This systematic review summarizes the deaths that have been associated with it since 1990. Extensive literature searches located 1105 articles of which 6 met the inclusion criteria. They reported 9 fatalities. The quality of these reports was too poor to establish causality beyond doubt. It is concluded that EDTA chelation continues to be associated with fatal outcomes.<br>[Traduction DeepL: ] |